Skip to main content

Advertisement

Log in

Membrane-Bound Toll-Like Receptors are Overexpressed in Peripheral Blood and Synovial Fluid Mononuclear Cells of Enthesitis-Related Arthritis Category of Juvenile Idiopathic Arthritis (JIA–ERA) Patients and Lead to Secretion of Inflammatory Mediators

  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

We examined expression and function of TLRs in enthesitis-related arthritis (ERA) patients. RNA levels of TLR1, TLR3, and TLRs 5–8 were measured in 24 ERA peripheral blood mononuclear cells (PBMC), 18 synovial fluid mononuclear cells (SFMC), and IRAK1, IRAK4, TRIF, TRAF3, and TRAF6 in 18 PBMC and 10 SFMC. IL-6 and IL-8 were measured in supernatants from ERA PBMC (n = 7), SFMC (n = 3), and healthy PBMC (n = 5) cultured with ligands for TLR1/2 (Pam 3-cys), TLR3 (poly I:C), TLR5 (flagellin), and TLR2/6 (zymosan). TLRs 1, 3, 5, and 6 were measured in whole blood (n = 20 ERA, seven healthy) and SFMC (n = 2) by flow cytometry. ERA PBMC compared to healthy PBMC and SFMC compared to ERA PBMC had higher RNA expression of TLR1, TLR3, TLR5, TLR6, IRAK1, IRAK4, TRIF, TRAF3, and TRAF6. TLR7 and TLR8 RNA expression was similar in all study groups. IL-6 and IL-8 levels were higher in stimulated ERA SFMC compared to ERA PBMC and in ERA PBMC compared to control PBMC. TLRs 1, 3, and 6 were also overexpressed at the protein level.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2004;124:783–801.

    Article  Google Scholar 

  2. Iwasaki A, Medzhitov R. Regulation of adaptive immunity by the innate immune system. Science. 2010;327:291–5.

    Article  PubMed  CAS  Google Scholar 

  3. Drexler SK, Foxwell BM. The role of toll-like receptors in chronic inflammation. Int J Biochem Cell Biol. 2009;42:506–18.

    Article  PubMed  Google Scholar 

  4. van der Heijden IM, Wilbrink B, Tchetverikov I, Schrijver IA, Schouls LM, Hazenberg MP, et al. Presence of bacterial DNA and bacterial peptidoglycans in joints of patients with rheumatoid arthritis and other arthritides. Arthritis Rheum. 2000;43:593–8.

    Article  PubMed  Google Scholar 

  5. Huang Q, Sobkoviak R, Jockheck-Clark AR, et al. Heat shock protein 96 is elevated in rheumatoid arthritis and activates macrophages primarily via TLR2 signaling. J Immunol. 2009;182:4965–73.

    Article  PubMed  CAS  Google Scholar 

  6. Andreakos E, Foxwell B, Feldmann M. Is targeting toll-like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine-driven inflammation? Immunol Rev. 2004;202:250–65.

    Article  PubMed  CAS  Google Scholar 

  7. Li M, Carpio DF, Zheng Y, Bruzzo P, Singh V, Ouaaz F, Medzhitov RM, Beg AA. An essential role of NF-κB/toll like receptor pathway in induction of inflammatory and tissue repair gene expression by necrotic cells. J Immunol. 2001;3:375–80.

    Google Scholar 

  8. Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390–2.

    PubMed  Google Scholar 

  9. Ellis JA, Munro JE, Ponsonby AE. Possible environmental determinants of juvenile idiopathic arthritis. Rheumatology. 2010;49:411–25.

    Article  PubMed  Google Scholar 

  10. Kunjir V, Venugopalan A, Chopra A. Profile of Indian patients with juvenile onset chronic inflammatory joint disease using the ILAR classification criteria for JIA: a community-based cohort study. J Rheumatol. 2010;37:1756–62.

    Article  PubMed  Google Scholar 

  11. Aggarwal A, Misra RN. Juvenile rheumatoid arthritis in India: rarity of antinuclear antibody and uveitis. Indian J Pediatr. 1996;63:301–4.

    Article  PubMed  CAS  Google Scholar 

  12. Saxena N, Aggarwal A, Misra RN. Is the enthesitis-related arthritis subtype of juvenile idiopathic arthritis a form of chronic reactive arthritis? Rheumatology. 2006;45:1129–32.

    Article  PubMed  CAS  Google Scholar 

  13. Agarwal S, Misra R, Aggarwal A. TLR ligands induce metalloproteinases expression in human fibroblast like synoviocytes from patients with juvenile idiopathic arthritis. Ind J Med Res. 2010;131:771–9.

    CAS  Google Scholar 

  14. Myles A, Aggarwal A. Expression of Toll-like receptors 2 and 4 is increased in peripheral blood and synovial fluid monocytes of patients with enthesitis-related arthritis subtype of juvenile idiopathic arthritis. Rheumatology. 2011;50:481–8.

    Article  PubMed  CAS  Google Scholar 

  15. Fitzner N, Clauberg S, Essman F, Liebmann J, Kolb-Bachofen V. Human skin endothelial cells can express all 10 TLR genes and respond to respective ligands. Clin Vaccine Immunol. 2008;15:138–46.

    Article  PubMed  CAS  Google Scholar 

  16. Iwshashi M, Yamamura M, Aita T, et al. Expression of toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis. Arthritis Rheum. 2004;50:1457–67.

    Article  Google Scholar 

  17. Radstake TR, Roelofs MF, Jenniskens YM, et al. Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma. Arthritis Rheum. 2004;50:3856–65.

    Article  PubMed  CAS  Google Scholar 

  18. Kim KW, Cho ML, Lee SH, et al. Human rheumatoid synovial fibroblasts promote osteoclastogenic activity by activating RANKL via TLR-2 and TLR-4 activation. Immunol Lett. 2007;110:54–64.

    Article  PubMed  CAS  Google Scholar 

  19. Ospelt C, Brentano F, Rengel Y, Stanczyk J, Kolling C, Tak PP, et al. Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: toll-like receptor expression in early and longstanding arthritis. Arthritis Rheum. 2008;58:3684–92.

    Article  PubMed  CAS  Google Scholar 

  20. Abreu MT, Arditi M. Innate immunity and toll-like receptors: clinical implications of basic science research. J Pediatr. 2004;144:421–9.

    Article  PubMed  CAS  Google Scholar 

  21. Janssens S, Beyaert R. Role of Toll-like receptors in pathogen recognition. Clin Microbiol Rev. 2003;16:637–46.

    Article  PubMed  CAS  Google Scholar 

  22. Joosten LA, Koenders MI, Smeets RL, et al. Toll-like receptor 2 pathway drives streptococcal cell wall-induced joint inflammation: critical role of myeloid differentiation factor 88. J Immunol. 2003;171:6145–53.

    PubMed  CAS  Google Scholar 

  23. Rhee SH, Im E, Riegler M, Kokkotou E, O’Brien M, Pothoulakis C. Pathophysiological role of Toll-like receptor 5 engagement by bacterial flagellin in colonic inflammation. Proc Natl Acad Sci USA. 2005;102:13610–5.

    Article  PubMed  CAS  Google Scholar 

  24. Kim KW, Cho ML, Oh HJ, Kim HR, Kang CM, Heo YM, Lee SH, Kim HY. TLR-3 enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis. Immunol Lett. 2009;124:9–17.

    Article  PubMed  CAS  Google Scholar 

  25. Meng L, Zhu W, Jiang C, He X, Hou W, Zheng F, Holmdahl R, Lu S. Toll-like receptor 3 upregulation in macrophages participates in the initiation and maintenance of pristane-induced arthritis in rats. Arthritis Res Ther. 2010;12:R103.

    Article  PubMed  Google Scholar 

  26. Agarwal SK, Wu M, Livingston CK, Parks DH, Mayes MD, Arnett FC, Tan FK. Toll-like receptor 3 upregulation by type I interferon in healthy and scleroderma dermal fibroblasts. Arthritis Res Ther. 2011;13:R3.

    Article  PubMed  CAS  Google Scholar 

  27. Koziczak-Holbro M, Littlewood-Evans A, Pollinger B, Kovarik J, Dawson J, Zenke G, et al. The critical role of kinase activity of interleukin-1 receptor-associated kinase 4 in animal models of joint inflammation. Arthritis Rheum. 2009;60:1661–71.

    Article  PubMed  CAS  Google Scholar 

  28. Maitra U, Davis S, Reilly CM, Li L. Differential regulation of Foxp3 and IL-17 expression in CD4 T helper cells by IRAK-1. J Immunol. 2009;182:5763–9.

    Article  PubMed  CAS  Google Scholar 

  29. Ahmad R, Sylvester J, Zafarullah M. MyD88, IRAK1 and TRAF6 knockdown in human chondrocytes inhibits interleukin-1-induced matrix metalloproteinase-13 gene expression and promoter activity by impairing MAP kinase activation. Cell Sig. 2007;19:2549–57.

    Article  CAS  Google Scholar 

  30. Potter C, Eyre S, Cope A, Worthington J, Barton A. Investigation of association between the TRAF family genes and RA susceptibility. Ann Rheum Dis. 2007;66:1322–6.

    Article  PubMed  Google Scholar 

  31. Kowalski ML, Wolska A, Grzegorczyk J, et al. Increased responsiveness to toll-like receptor 4 stimulation in peripheral blood mononuclear cells from patients with recent onset rheumatoid arthritis. Mediators Inflamm. 2008;2008:132732.

    Article  PubMed  CAS  Google Scholar 

  32. Jung YO, Cho ML, Lee SY, et al. Synergism of toll-like receptor 2 (TLR2), TLR4, and TLR6 ligation on the production of tumor necrosis factor (TNF)-alpha in a spontaneous arthritis animal model of interleukin (IL)-1 receptor antagonist-deficient mice. Immunol Lett. 2009;123:138–43.

    Article  PubMed  CAS  Google Scholar 

  33. van Heel DA, Ghosh S, Butler M, Hunt K, Foxwell BM, Mengin-Lecreulx D, et al. Synergistic enhancement of Toll-like receptor responses by NOD1 activation. Eur J Immunol. 2005;35:2471–6.

    Article  PubMed  Google Scholar 

  34. Saxena N, Misra R, Aggarwal A. Is the enthesitis-related arthritis subtype of juvenile idiopathic arthritis a form of chronic reactive arthritis? Rheumatology. 2006;45:1129.

    Article  PubMed  CAS  Google Scholar 

  35. Edwards CJ. Commensal gut bacteria and the etiopathogenesis of rheumatoid arthritis. J Rheumatol. 2008;35:1477–14797.

    PubMed  Google Scholar 

  36. Opal SM, Huber CE. Bench-to-bedside review: toll-like receptors and their role in septic shock. Crit Care. 2002;6:125–36.

    Article  PubMed  Google Scholar 

  37. Ungaro R, Fukata M, Hsu D, Hernandez Y, Breglio K, Chen A, et al. A novel toll-like receptor 4 (TLR4) antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis. Am J Physiol Gastrointest Liver Physiol. 2009;296:G1167–79.

    Article  PubMed  CAS  Google Scholar 

  38. Arslan F, de Kleijn DP, Timmers L, Doevendans PA, Pasterkamp G. Bridging innate immunity and myocardial ischemia/reperfusion injury: the search for therapeutic targets. Curr Pharm Des. 2008;14:1205–16.

    Article  PubMed  CAS  Google Scholar 

  39. Loiarro M, Capolunghi F, Fantò N, Gallo G, Campo S, Arseni B, et al. Pivotal advance: inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound. J Leukoc Biol. 2007;82:801–10.

    Article  PubMed  CAS  Google Scholar 

  40. Song KW, Talamas FX, Suttmann RT, Olson PS, Barnett JW, Lee SW, et al. The kinase activities of interleukin-1 receptor associated kinase (IRAK)-1 and 4 are redundant in the control of inflammatory cytokine expression in human cells. Mol Immunol. 2009;46:1458–66.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported by a grant from the Indian Council of Medical Research and Department of Biotechnology, Government of India to A.A. A.M. is supported by Council of Scientific and Industrial Research–Senior Research Fellowship.

Conflict of Interest

The authors declare no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Amita Aggarwal.

Electronic Supplementary Material

Below is the link to the electronic supplementary material.

Supplementary Fig. S1

RNA levels of TLRs normalized to 18S rRNA. a Fold change in patient PBMC (n = 24) relative to healthy PBMC. b Fold change in patient (n = 7) SFMC relative to corresponding PBMC (JPEG 58 kb)

Supplementary Fig. S2

RNA levels of adaptors normalized to GAPDH. a Fold change in patient PBMC (n = 18) relative to healthy PBMC. b Fold change in patient (n = 10) SFMC relative to corresponding PBMC (JPEG 60 kb)

Supplementary Fig. S3

Flow cytometry histograms comparing expression of various toll-like receptors in whole blood upon blocking Fc receptors with 10% human serum. Samples were treated with either HI Serum heat inactivated serum, UT Serum untreated serum (used without activation), or left untreated (no serum) (JPEG 214 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Myles, A., Rahman, M.T. & Aggarwal, A. Membrane-Bound Toll-Like Receptors are Overexpressed in Peripheral Blood and Synovial Fluid Mononuclear Cells of Enthesitis-Related Arthritis Category of Juvenile Idiopathic Arthritis (JIA–ERA) Patients and Lead to Secretion of Inflammatory Mediators. J Clin Immunol 32, 488–496 (2012). https://doi.org/10.1007/s10875-011-9640-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-011-9640-5

Keywords

Navigation